APA (7th ed.) Citation

Osterborg, A., Dyer, M., Bunjes, D., Pangalis, G., Bastion, Y., Catovsky, D., . . . Stahel, R. (1997). Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15(4), 1567. https://doi.org/10.1200/JCO.1997.15.4.1567

Chicago Style (17th ed.) Citation

Osterborg, A., et al. "Phase II Multicenter Study of Human CD52 Antibody in Previously Treated Chronic Lymphocytic Leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 15, no. 4 (1997): 1567. https://doi.org/10.1200/JCO.1997.15.4.1567.

MLA (9th ed.) Citation

Osterborg, A., et al. "Phase II Multicenter Study of Human CD52 Antibody in Previously Treated Chronic Lymphocytic Leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 15, no. 4, 1997, p. 1567, https://doi.org/10.1200/JCO.1997.15.4.1567.